Tweak receptor agonists as anti-angiogenic agents
US7208151B2 · kind B2 · utility
19Cited by
11References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 12, 2001 |
| Grant date | Apr 24, 2007 |
| Priority date | — |
| Expiry date | Sep 21, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/73
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods of modulating angiogenesis and inhibiting tumor progression by using TWEAK receptor (Fn14) agonists. In particular, methods for inhibiting angiogenesis are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.